DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Revenue

In the year 2025, DAE HWA Pharmaceutical had annual revenue of 143.06B KRW, down -4.25%. DAE HWA Pharmaceutical had revenue of 33.70B in the quarter ending December 31, 2025, a decrease of -15.97%.

• Revenue: 143.06B
• Revenue Growth: -4.25%
• P/S Ratio: 1.57
• Revenue / Employee: 464.48M
• Employees: n/a
• Market Cap: 224.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	143.06B	-6.35B	-4.25%
Dec 31, 2024	149.41B	8.05B	5.69%
Dec 31, 2023	141.36B	9.45B	7.16%
Dec 31, 2022	131.91B	14.75B	12.59%
Dec 31, 2021	117.16B	7.81B	7.15%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error